Biotop-report 2012

Daniela Gebauer

Tel. [phone]

[e-mail]

Katharina Meindl

Tel. [phone]

[e-mail]

Karin Hofelich

Tel. [phone]

[e-mail] 

Tel. [phone]

Contact media sales team

Publication date: 

February 25

th

, 2012

Special

Industrial Biotechnology 2012 (Vol. 3)

Publication date: 

March 31

st

, 2012

Supplement

Healthcare 2012 (Vol. 6)

Publication date:  

June 30

th

, 2012

Advertising close: 

June 18

th

, 2012

Special Topic Life Science in 

GoingPublic Magazin 7/2012

Publication Date: 

September 15

th

, 2012

Advertising close: 

September 3

rd

, 2012

Special edition

Biotechnology 2012 (Vol. 14)

Publication date: 

November 14

th

, 2012

Advertising close: 

November 2

nd

, 2012

Supplement

Medical Technology 2012 (Vol. 10)

Only GoingPublic Magazin’s Special “Industrial Biotechnology” 

is published in English, all others in German.

Further info: www.goingpublic.de 

GoingPublic´s 

classic

Expertise in Life Sciences

---

24

BioTOPics 44 | May 2012 

BioTOP-Report

Life Sciences

Excellent Research in Berlin-Brandenburg

Berlin-Brandenburg is regarded both nationally and internationally as one of the most important centers of 

modern biotechnology. The region provides optimal conditions: It is one of the TOP life sciences locations 

worldwide – with five universities, numerous colleges and a unique density of extramural research centers. 

Renowned facilities in the field of biotechnology and the life sciences include four Max Planck Institutes, two 

Fraunhofer Institutes, two Leibniz Institutes and two Helmholtz Association centers. The region also has an 

abundant landscape of clinics, led by the Charité – Universitätsmedizin Berlin. 

Biotechnology is a major contributor to the development of the 

modern life sciences. It is highly interdisciplinary, encompass-

ing pharmaceutics research, diagnostics, theranostics, molecu-

lar genetics and the development of innovative biomaterials 

for medical applications. In addition to scientific expertise, the 

Berlin-Brandenburg region offers excellent conditions for close 

networking between different science disciplines, research cen-

ters, industry and (clinical) users. 

No less than seven technology parks focusing on the life sciences 

are situated in the region (see p. 18-22). One of Germany’s larg-

est biotechnology parks is Campus Berlin-Buch, with important 

facilities such as the Max Delbrück Center for Molecular Medicine 

(MDC), which is part of the Helmholtz Association, and the Leib-

JANUARY 2011

Prof. Dr. Andreas Radbruch of the  German Rheumatism Research  Center Ber-

lin (DRFZ) receives Advanced Grant of the  European Research Council (ERC) 

in the amount of 2.5  million  Euro 

++++ 

Prof. Dr. Klaus Rajewsky receives 

Advanced Grant of the European Research Council (ERC) in the amount of 2.5 

million Euro and establishes working group at the MDC

FEBRUARY 2011

ESGI project (the European Sequencing and Genotyping Infrastructure), coor-

dinated by the Max-Planck-Institute for Molecular Genetics, starts

MARCH 2011

Charité-scientist Andrea Ode of the Julius Wolff Institute wins BIONNALE 

Speed Lecture Award 

++++ 

Prof. Dr. Oliver Daumke from the Max Delbrück 

Center for Molecular Medicine (MDC) Berlin-Buch receives “Bayer Early Excel-

lence in Science Award 2010” for biology

APRIL 2011

Berlin research consortium becomes part of the German Center for 

 Cardiovascular Research (DZHK) 

++++ 

Dr. Daniel Toben of Charité receives 

Raisz-Drezner-Award of the American Society of Bone and Mineral Research 

(ASBMR) 

++++ 

BioTOP and BCRT publish technology report on Regenerative 

Medicine in Berlin-Brandenburg 

++++ 

Prof. Dr. Jan Schwab of the Department 

of Neurology at the Charité and the Berlin-Brandenburg Center for Regenera-

tive Therapies (BCRT) received the Novartis Award for therapy relevant phar-

macological research

MAY 2011

Researchers at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-

Buch of the Helmholtz Association have discovered what it is that enables 

embryonic stem cells to develop into the most diverse cell types and hence be 

pluripotent 

++++ 

An international team around researchers at the Max Planck 

Institute of Colloids and Interfaces in Potsdam has developed a vaccine based 

on a carbohydrate against the bacterium Clostridium difficile, which causes 

severe intestinal infections especially in hospitals

JUNE 2011

The MDC, Charité and German Heart Institute Berlin (DHZB) are appointed as 

the Berlin sites for the German Centers for Cardiovascular Research (DZHK) 

++++ 

Andreas Radbruch, Science Director of the German Rheumatism 

Research Center (DRFZ), receives the world’s most prestigious rheumatol-

ogy award, the Carol-Nachman Prize, for his research into the immunological 

memory for inflammatory-rheumatic diseases

Prof. Dr. Volker Haucke

Scientific Director of the Leibniz Institute 

for Molecular Pharmacology (FMP)

We are experiencing exciting times in Berlin and at the Cam-

pus Buch, where biology, pharmacology, and chemistry meet 

– with the FMP serving as a melting pot. The Campus and the 

FMP have gained a lot of international recognition over the 

last years and serve as a magnet for top scientists from all 

around the globe.

---